Sinopharm
1099.HK
C$3.41
Share price
-1.32%
Change (1 day)
4.67%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Sinopharm (1099.HK) - Cash on Hand
Cash on Hand as of December 2024 : C$10.24 Billion
According to Sinopharm's latest financial reports the company has C$10.24 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Sinopharm - Cash on Hand chart (from 2008 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | C$11.97 B | 10.2% |
| 2022-12-31 | C$10.86 B | 24.76% |
| 2021-12-31 | C$8.70 B | -11.3% |
| 2020-12-31 | C$9.81 B | 33.98% |
| 2019-12-31 | C$7.32 B | -8.3% |
| 2018-12-31 | C$7.99 B | 27.55% |
| 2017-12-31 | C$6.26 B | 26.55% |
| 2016-12-31 | C$4.95 B | 15.83% |
| 2015-12-31 | C$4.27 B | 49.7% |
| 2014-12-31 | C$2.85 B | 15.91% |
| 2013-12-31 | C$2.46 B | 57.54% |
| 2012-12-31 | C$1.56 B | -26.21% |
| 2011-12-31 | C$2.11 B | 87.5% |
| 2010-12-31 | C$1.13 B | -3.07% |
| 2009-12-31 | C$1.16 B | 226.98% |
| 2008-12-31 | C$0.35 B | 33.31% |
| 2007-12-31 | C$0.26 B | -2.48% |
| 2006-12-31 | C$0.27 B |